Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.080
-0.030 (-1.42%)
At close: Jul 2, 2026, 4:00 PM EDT
2.065
-0.015 (-0.71%)
After-hours: Jul 2, 2026, 7:19 PM EDT
Allogene Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $10 | Buy | Maintains | $10 | +380.77% | May 29, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $7 | Buy | Reiterates | $7 | +236.54% | May 14, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $9 | Buy | Maintains | $9 | +332.69% | May 14, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $14 | Buy | Maintains | $14 | +573.08% | May 14, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 14, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Upgrades n/a | Hold | Upgrades | n/a | n/a | Apr 16, 2026 |
| Jefferies | Jefferies | Buy Maintains $6 → $10 | Buy | Maintains | $6 → $10 | +380.77% | Apr 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.